ArticleThe Journal of clinical investigation2022

Boosting NAD+ blunts TLR4-induced type I IFN in control and systemic lupus erythematosus monocytes.

Jing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.